Cardiac prosthetics are chronic alternatives that replace a damaged or diseased part in the body.Cardiac prosthetic devices are used in the treatment of blockages in heart valves. Implantation of cardiac prosthetic devices is being increasingly accepted as one of the common procedures due to a rise in the number of patients suffering from valvular diseases. Prosthetic valve thrombosis (PVT), prosthetic valve endocarditis (PVE), mechanical hemolytic anemia and thromboembolism are some of the complications that involve the failure of primary valves.

Furthermore, these devices tend to improve the quality of life by reducing the morbidity and mortality rate by replacing diseased valves. It is been estimated that more than 60,000 patients undergo heart valve replacement in the U.S. every year. Thus, the usage and acceptance of cardiac prosthetic devices is on risemainly due to technological advances and better performance. Escalation in cardiac disorder prevalence is contributed by the factors such as rise in geriatric population, high obesity epidemic and rapidly changing lifestyle. The global cardiac prosthetic devices market was valued at USD 2,945.3 million in the year 2012 and is expected to record a growth rate of 8.7% during the forecast period from 2013 to 2019, to reach an estimated value of USD 5,290.0 million by 2019.

global-cardiac-prosthetic-devices-market-by-segments-2012

The cardiac prosthetic devices market can be analyzed by the types of heart valves and pacemakers. The various types of heart valves currently available are mechanical heart valves, tissue heart valves and transcatheter heart valves. These devices are used to replace the affectedheart valves in patients. Heart valve disorders can arise from three types of malfunction: regurgitation, stenosis and atresia. A heart valve disease, if not treated in time, can lead to various heart diseases such as stroke, heart failure, cardiac arrest and blood clots. Rising geriatric population, changing lifestyle and increasing partnership among vendors are the factors influencing the growth of the heart valves market globally. Pacemakers are further categorized as implantable pacemaker and external pacemaker. Pacemakers are cardiac prosthetic devices that assist in controlling abnormal heart rhythms. These devices are implanted in patients suffering from cardiac arrhythmia, a heart disorder featured by an uneven pattern of heartbeats.

Geographically, North America accounts for the largest percentage share of the global cardiac prosthetic devices market accounting for over35% of the total market. This is justified by the presence of technologically updated infrastructure and well trained healthcare professionalsin this region compared to other regions. In addition, rising prevalence of cardiac diseases and established healthcare policies has further augmented the growth and development of cardiac prosthetic devices market in this region.Asia-Pacific region is anticipated to record high growth rate owing to increased participation of respective governments in improving the overall healthcare sector and huge untapped potential in these regions. In addition, rise in disposable incomes and increased preference of the population to avail technologically advanced medical solutions further support the growth of cardiac prosthetic devices market. 

The overall cardiac prosthetic devices market is highly fragmented with the presence of both established and emerging companies in this field that includes Edwards Lifesciences Corporation, Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Sorin Group and others. The factors that contribute in the growth of overall cardiac prosthetic devices are continuous product modifications and upgradations followed by technological advances and increased preference for minimally invasive procedures. However, high cost of the products and procedures may limit the growth prospects for the development of cardiac prosthetic devices market.

The research report comprises a comprehensive analysis of the global market for cardiac prosthetic devices. The report throws light on factors such as the market’s competitive landscape, production capacities of key businesses, resource utilization, demand and supply patterns, and recent developments in the market, with the help of qualitative and quantitative elaboration on the market. The market study focuses mainly on the drivers, opportunities, and restraints that are shaping the global market for cardiac prosthetic devices. 

The facts, figures, and data in the report are based on a variety of primary and secondary research methodologies. Useful insights from industry experts are also included in the report. Porter’s five forces and SWOT analysis are the two key analytical tools used to analyze the strengths, weaknesses, challenges, and opportunities in the market.  

With an extensive collection of data elements such as tables, charts, graphs, and figures, the report on the global cardiac prosthetic devices market presents demand, resource utilization, and investment patterns in an easy-to understand manner. The historical data, along with the current market statistics, make it easy to analyze the development of the market over the past years. 

The report analyzes the market’s state in key regional market segments to present a comprehensive comparative analysis. The report’s section on competitive analysis includes details of key businesses operating in the global cardiac prosthetic devices market in terms of company overview, product portfolio, financial performance of businesses, demand drivers, and key developments.

Overview of the Global Cardiac Prosthetic Devices Market

The report states that the rising prevalence of a number of cardiovascular diseases related to cerebrovascular, valvular, rheumatic, coronary artery, and peripheral vascular conditions is the key demand driver for the global cardiac prosthetic devices market. A number of other factors, such as rising preference for minimally invasive treatment methods, continuous upgradation and modification of products, rising population of obese and aged people across the globe, and busy modern lifestyles, are also significantly contributing to a constant rise in demand for cardiac prosthetic devices.

The report segments the global cardiac prosthetic devices market broadly on the basis of types of heart valves and pacemakers, and key regional markets. On the basis of types of heart valves, the market is segmented into mechanical heart valves, tissue heart valves, and transcatheter heart valves. Types of pacemakers studied in the report include implantable and external pacemakers. The regional markets of North America, Asia Pacific, Europe, and the Rest of the World (RoW) are studied in the report.

With a market share of nearly 35%, the regional market of North America led the global cardiac prosthetic devices market in 2012. Established healthcare policies, easy availability of high-end technologies, updated infrastructure, and presence of well-trained healthcare personnel are responsible for the dominant position of the North America market for cardiac prosthetic devices. 

The market for cardiac prosthetic devices is expected to flourish at the fastest pace in the Asia Pacific market owing to rising participation of government bodies in an effort to improve healthcare facilities in these regions.

Company Profiles Included in the Report

The report includes detailed profiles of key businesses operating in this highly fragmented marketplace, including Boston Scientific Corporation, St. Jude Medical, Edwards Lifesciences Corporation, Medtronic, Inc., and Sorin Group.

Major geographies analyzed under this research report are:

  • Europe
  • North America 
  • Asia-Pacific 
  • Rest of the World 

This report gives you access to decisive data such as:

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
               1.3.1.1 Secondary Research
               1.3.1.2 Primary Research

Chapter 2 Executive Summary
2.1 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
      3.2.1 Rising Geriatric Population
      3.2.2 Rising Prevalence of Disorders such as Hypertension, Diabetes and Obesity
      3.2.3 Increasing Demand for Minimally-Invasive Procedures
3.3 Market Restraints
      3.3.1 Implementation of Affordable Healthcare Act
      3.3.2 Strict Approval Process from Government Bodies
3.4 Market Opportunities
      3.4.1 Big Opportunities in Emerging Economies with High Unmet Needs
      3.4.2 Huge Scope for Alliance with Organizations having Complementary Strength
3.5 Porter’s Five Forces Analysis for the Global Cardiac Prosthetic Devices Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis for the Global Cardiac Prosthetic Devices Market, by Geography
3.7 Market Share by Key Players of Global Cardiac Prosthetic Devices Market, 2012
      3.7.1 Global Cardiac Prosthetic Devices Market Share, by Key Players, 2012 (%)
 
Chapter 4 Cardiac Prosthetic Devices Market, by Segments
4.1 Overview
      4.1.1 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
4.2 Heart Valves
      4.2.1 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
      4.2.2 Mechanical Heart Valves
               4.2.2.1 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
      4.2.3 Tissue Heart Valves
               4.2.3.1 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
               4.2.3.2 Stented Tissue Valve
                          4.2.3.2.1 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
               4.2.3.1 Stentless Tissue Valve
                          4.2.3.1.1 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
      4.2.4 Transcatheter Heart Valves
               4.2.4.1 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
4.3 Pacemaker
      4.3.1 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
      4.3.2 Implantable Pacemaker
      4.3.3 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
              4.3.3.1 Single-Chamber Battery Pacemaker
                         4.3.3.1.1 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
              4.3.3.2 Dual-Chamber Battery Pacemaker
                         4.3.3.2.1 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
              4.3.3.3 Triple-Chamber Battery Pacemaker
                         4.3.3.3.1 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
      4.3.4 External Pacemaker
              4.3.4.1 Global External Pacemaker Market, 2011 – 2019 (USD Million)
 
Chapter 5 Cardiac Prosthetic Devices Market, by Geography
5.1 Overview
      5.1.1 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.2 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
5.3 North America
      5.3.1 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.4 Europe
      5.4.1 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.5 Asia-Pacific
      5.5.1 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.6 Rest of the World (RoW)
      5.6.1 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
 
Chapter 6 Recommendations
6.1 Market Strategies for Success
6.2 Barriers to be Considered
 
Chapter 7 Company Profiles
7.1 Abbott Laboratories
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Product Portfolio
      7.1.4 Business Strategies
      7.1.5 Recent Developments
7.2 Abiomed, Inc.
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Product Portfolio
      7.2.4 Business Strategies
      7.2.5 Recent Developments
7.3 AtriCure, Inc.
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Portfolio
      7.3.4 Business Strategies
      7.3.5 Recent Developments
7.4 Boston Scientific Corporation
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
      7.4.5 Recent Developments
7.5 Edward Lifesciences Corporation
      7.5.1 Company overview
      7.5.2 Financial overview
      7.5.3 Product Portfolio
      7.5.4 Business Strategies
      7.5.5 Recent Developments
7.6 Medtronic, Inc.
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
      7.6.5 Recent Developments
7.7 Siemens Healthcare
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
      7.7.5 Recent Developments
7.8 Sorin Group
      7.8.1 Company Overview
      7.8.2 Financial Overview
      7.8.3 Product Portfolio
      7.8.4 Business Strategies
      7.8.5 Recent Developments
7.9 St. Jude Medical, Inc.
      7.9.1 Company Overview
      7.9.2 Financial Overview
      7.9.3 Product Portfolio
      7.9.4 Business Strategies
      7.9.5 Recent Developments
List of Tables
 
TABLE 1 Market Snapshot: Global Cardiac Prosthetic Devices Market (2012 & 2019)
TABLE 2 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
TABLE 3 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 4 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 7 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 8 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 9 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 11 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

List of Figures

 

FIG. 1 Cardiac Prosthetic Devices: Market Segmentation

FIG. 2 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)

FIG. 3 Porter’s Five Forces Analysis: Cardiac Prosthetic Devices Market

FIG. 4 Market Attractiveness Analysis: Global Cardiac Prosthetic Devices Market, by Geography

FIG. 5 Cardiac Prosthetic Devices: Market Share, by Key Players, 2012 (%)

FIG. 6 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)

FIG. 7 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)

FIG. 8 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)

FIG. 9 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)

FIG. 10 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)

FIG. 11 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)

FIG. 12 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)

FIG. 13 Global External Pacemaker Market, 2011 – 2019 (USD Million)

FIG. 14 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)

FIG. 15 Abbott Laboratories, Annual Revenue: 2010 – 2012 (USD Billion)

FIG. 16 Abiomed, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 17 AtriCure, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 18 Boston Scientific Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 19 Edward Lifesciences Corporation, Net Sales: 2010 – 2012 (USD Billion)

FIG. 20 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 21 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 22 Sorin Group, Net Sales: 2010 – 2012 (USD Million)

FIG. 23 St. Jude Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Cardiac Prosthetic Market